However, large molecular substances are confined within the intestinal lumen due to their inability to pass through tightly connected narrow channels
Your doctor will start you on a low dose and gradually increase it to minimise discomfort
Consequently, a better ability to intensify treatment upon failure, presumably because of tighter control, may add to the long-term efficacy of GLP-1RA and improved outcomes for patients
In contrast, those treated with GLP-1 RAs showed significant reductions in the risks of mortality, MACEs, and MAKEs during a median follow-up period of 2.3 years
[7] [8] Readers should check the current NICE Technology Appraisal for tirzepatide in weight management and the emc SmPC (medicines.org.uk) for the most up-to-date information on its licensed indications and eligibility criteria in the UK, as guidance may be updated
Individual response varies based on medication formulation, baseline metabolic status, adherence to lifestyle modifications, and gastrointestinal tolerance